{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:14:49Z","timestamp":1770819289572,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00120-025-02663-w","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:28:24Z","timestamp":1755764904000},"page":"174-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Auff\u00e4llige Kontrastmittelkinetik bei muzin\u00f6sem Prostatakarzinom","Atypical contrast enhancement in mucinous prostate cancer"],"prefix":"10.1007","volume":"65","author":[{"given":"Julio Ruben","family":"Rodas Garzaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Kravchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Moersler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Siepmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Stemplinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gilfrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"4","key":"2663_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00261-019-01956-x","volume":"44","author":"K Yamada","year":"2019","unstructured":"Yamada\u00a0K, Kozawa\u00a0N, Nagano\u00a0H, Fujita\u00a0M, Yamada\u00a0K (2019) MRI features of mucinous adenocarcinoma of the prostate: report of four cases. Abdom Radiol (NY) 44(4):1261\u20131268. https:\/\/doi.org\/10.1007\/s00261-019-01956-x (PMID: 30810795)","journal-title":"Abdom Radiol (NY)"},{"issue":"6","key":"2663_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1055\/a-1084-4042","volume":"192","author":"B Valentin","year":"2020","unstructured":"Valentin\u00a0B, Blondin\u00a0D, Ullrich\u00a0T et\u00a0al (2020) Can you trust the prostate imaging reporting and data system (PI-RADS) in special cases? Rofo 192(6):580\u2013583. https:\/\/doi.org\/10.1055\/a-1084-4042 (PMID: 31945788)","journal-title":"Rofo"},{"issue":"6","key":"2663_CR3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13244-015-0426-9","volume":"6","author":"V Panebianco","year":"2015","unstructured":"Panebianco\u00a0V, Barchetti\u00a0F, Barentsz\u00a0J et\u00a0al (2015) Pitfalls in interpreting mp-MRI of the prostate: a\u00a0pictorial review with pathologic correlation. Insights Imaging 6(6):611\u2013630. https:\/\/doi.org\/10.1007\/s13244-015-0426-9 (PMID: 26385690, PMCID: PMC4656245)","journal-title":"Insights Imaging"},{"issue":"5","key":"2663_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/1754-9485.13327","volume":"66","author":"PJ Horsley","year":"2022","unstructured":"Horsley\u00a0PJ, Sheehan-Dare\u00a0G, Mastrocostas\u00a0K et\u00a0al (2022) Prostate adenocarcinoma with mucinous features\u2014Is it PSMA avid? J\u00a0Med Imaging Radiat Oncol 66(5):637\u2013640. https:\/\/doi.org\/10.1111\/1754-9485.13327 (PMID: 34524723)","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"3","key":"2663_CR5","doi-asserted-by":"publisher","first-page":"e56563","DOI":"10.7759\/cureus.56563","volume":"16","author":"AA Khokhar","year":"2024","unstructured":"Khokhar\u00a0AA, Howles\u00a0SA, Leiblich\u00a0AW, Samdani\u00a0K, Ahmed\u00a0M (2024) Mucinous adenocarcinoma of the prostate with normal prostate-specific antigen levels, pulmonary metastasis, and the absence of nodal disease: a\u00a0case report. Cureus 16(3):e56563. https:\/\/doi.org\/10.7759\/cureus.56563 (PMID: 38646307, PMCID: PMC11029818)","journal-title":"Cureus"},{"key":"2663_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.3389\/fonc.2019.01467","volume":"9","author":"F Zhao","year":"2020","unstructured":"Zhao\u00a0F, Yu\u00a0X, Xu\u00a0M et\u00a0al (2020) Mucinous prostate cancer shows similar prognosis to typical prostate acinar carcinoma: a\u00a0large population-based and propensity score-matched study. Front Oncol 9:1467. https:\/\/doi.org\/10.3389\/fonc.2019.01467 (PMID: 31998638, PMCID: PMC6962295)","journal-title":"Front Oncol"},{"issue":"2","key":"2663_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","volume":"87","author":"JJ Twilt","year":"2025","unstructured":"Twilt\u00a0JJ, Saha\u00a0A, Bosma\u00a0JS et\u00a0al (2025) Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study. Eur Urol 87(2):240\u2013250. https:\/\/doi.org\/10.1016\/j.eururo.2024.09.035 (PMID: 39438187, PMCID: PMC11769734)","journal-title":"Eur Urol"},{"issue":"2","key":"2663_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.eururo.2024.11.022","volume":"87","author":"AB Dias","year":"2025","unstructured":"Dias\u00a0AB, Moore\u00a0CM, Renard-Penna\u00a0R, Giganti\u00a0F (2025) Biparametric versus multiparametric magnetic resonance imaging in prostate cancer: A\u00a0choice or a\u00a0fine balance? Eur Urol 87(2):251\u2013252. https:\/\/doi.org\/10.1016\/j.eururo.2024.11.022 (PMID: 39690096)","journal-title":"Eur Urol"},{"key":"2663_CR9","doi-asserted-by":"publisher","first-page":"504381","DOI":"10.3389\/fonc.2020.504381","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang\u00a0Y, Shen\u00a0H, Liao\u00a0K et\u00a0al (2020) Case report: prostate adenocarcinoma with mucinous features of normal-level serum PSA, atypical imaging, biopsy-negative, and peculiar urethrocystoscopic manifestation. Front Oncol 10:504381. https:\/\/doi.org\/10.3389\/fonc.2020.504381 (PMID: 33425711, PMCID: PMC7786235)","journal-title":"Front Oncol"},{"issue":"1","key":"2663_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1148\/radiol.202949","volume":"302","author":"AF Kanas","year":"2022","unstructured":"Kanas\u00a0AF, Fenelon\u00a0SS, Santos\u00a0JMMM, Coelho\u00a0RF, Guglielmetti\u00a0GB, Nahas\u00a0WC, Viana\u00a0PCC (2022) Case 297: mucinous adenocarcinoma of the prostate. Radiology 302(1):238\u2013242","journal-title":"Radiology"},{"key":"2663_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35323","author":"C Siech","year":"2024","unstructured":"Siech\u00a0C, de Angelis\u00a0M, Jannello\u00a0LMI et\u00a0al (2024) Life expectancy in rare histological prostate cancer subtypes. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.35323 (PMID: 39740082)","journal-title":"Int J Cancer"},{"key":"2663_CR12","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2025) S3-Leitlinie Prostatakarzinom, Langversion 8.01. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/prostatakarzinom\/. Zugegriffen: 26. Mai 2025 (AWMF-Registernummer: 043-022OL)"},{"key":"2663_CR13","unstructured":"Cornford P, Tilki D, van den Bergh RCN et\u00a0al (2025) EAU \u2013 EANM \u2013 ESTRO \u2013 ESUR \u2013 ISUP \u2013 SIOG Guidelines on Prostate Cancer. Edn. 2024. https:\/\/uroweb.org\/guidelines\/prostate-cancer. Zugegriffen: 26. Mai 2025"},{"issue":"10","key":"2663_CR14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1007\/s10147-024-02580-6","volume":"29","author":"T Tanegashima","year":"2024","unstructured":"Tanegashima\u00a0T, Shiota\u00a0M, Kimura\u00a0T et\u00a0al (2024) Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement. Int J Clin Oncol 29(10):1586\u20131593. https:\/\/doi.org\/10.1007\/s10147-024-02580-6 (PMID: 38976182)","journal-title":"Int J Clin Oncol"},{"issue":"25","key":"2663_CR15","doi-asserted-by":"publisher","first-page":"00105-1","DOI":"10.1016\/j.euo.2025.04.011","volume":"S2588\u20139311","author":"A Giesen","year":"2025","unstructured":"Giesen\u00a0A, De Preter\u00a0N, Fazekas\u00a0T et\u00a0al (2025) Direct treatment of all visible tumour in synchronous oligometastatic prostate cancer: total eradication of tumour or the full monty treatment. Eur Urol Oncol S2588\u20139311(25):00105\u20111. https:\/\/doi.org\/10.1016\/j.euo.2025.04.011 (PMID: 40300920)","journal-title":"Eur Urol Oncol"},{"key":"2663_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00890-4","author":"A Matsukawa","year":"2024","unstructured":"Matsukawa\u00a0A, Yanagisawa\u00a0T, Fazekas\u00a0T et\u00a0al (2024) Salvage therapies for biochemical recurrence after definitive local treatment: a\u00a0systematic review, meta-analysis, and network meta-analysis. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-024-00890-4 (PMID: 39266730)","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-025-02663-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-025-02663-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:29:01Z","timestamp":1770816541000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-025-02663-w"}},"subtitle":["Grenzen der PI-RADS (Prostate Imaging Reporting and Data System)-Klassifikation und Konsequenzen f\u00fcr die moderne Bildgebung","Limitations of the PI-RADS (Prostate Imaging Reporting and Data System) classification and implications for modern imaging"],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1007\/s00120-025-02663-w","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"9 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.R.\u00a0Rodas Garzaro, A.\u00a0Kravchuk, J.\u00a0Moersler, S.\u00a0Siepmann, E.\u00a0Stemplinger, F.\u00a0Eder, M.\u00a0May und C.\u00a0Gilfrich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}